hrs8179
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Feb 15, 2023 (NCT05690711)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06732648 | Phase 2/Phase 3 (Phase 3) | Dec 31, 2024 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
| NCT05690711 | Phase 2 | Feb 15, 2023 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1